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Abstract
During neural development, epigenetic modulation of chromatin acetylation is part of a dynamic, sequential and
critical process to steer the fate of multipotent neural progenitors toward a speciﬁc lineage. Pan-HDAC inhibitors
(HDCis) trigger neuronal differentiation by generating an “acetylation” signature and promoting the expression of
neurogenic bHLH transcription factors. Our studies and others have revealed a link between neuronal differentiation
and increase of mitochondrial mass. However, the neuronal regulation of mitochondrial biogenesis has remained
largely unexplored. Here, we show that the HDACi, sodium butyrate (NaBt), promotes mitochondrial biogenesis via the
NRF-1/Tfam axis in embryonic hippocampal progenitor cells and neuroprogenitor-like PC12-NeuroD6 cells, thereby
enhancing their neuronal differentiation competency. Increased mitochondrial DNA replication by several pan-HDACis
indicates a common mechanism by which they regulate mitochondrial biogenesis. NaBt also induces coordinates
mitochondrial ultrastructural changes and enhanced OXPHOS metabolism, thereby increasing key mitochondrial
bioenergetics parameters in neural progenitor cells. NaBt also endows the neuronal cells with increased mitochondrial
spare capacity to confer resistance to oxidative stress associated with neuronal differentiation. We demonstrate that
mitochondrial biogenesis is under HDAC-mediated epigenetic regulation, the timing of which is consistent with its
integrative role during neuronal differentiation. Thus, our ﬁndings add a new facet to our mechanistic understanding
of how pan-HDACis induce differentiation of neuronal progenitor cells. Our results reveal the concept that epigenetic
modulation of the mitochondrial pool prior to neurotrophic signaling dictates the efﬁciency of initiation of neuronal
differentiation during the transition from progenitor to differentiating neuronal cells. The histone acetyltransferase
CREB-binding protein plays a key role in regulating the mitochondrial biomass. By ChIP-seq analysis, we show that
NaBt confers an H3K27ac epigenetic signature in several interconnected nodes of nuclear genes vital for neuronal
differentiation and mitochondrial reprogramming. Collectively, our study reports a novel developmental epigenetic
layer that couples mitochondrial biogenesis to neuronal differentiation.
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In the last decade, epigenetic modiﬁcation of global
chromatin landscape has emerged as a key mechanism
regulating gene expression in a temporal and spatial
manner during neurogenesis1–3. Notably, the neurogenic
phase is associated with a unique histone acetylation signature in neural stem/progenitor cells that favors neuronal
fate, lineage progression, and differentiation4. In contrast,
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low levels of acetylation confer astrocytic differentiation
potential, while intermediate histone acetylation levels
support oligodendrocytic fate5,6. Such acetylation homeostasis is determined by the interplay between two classes
of antagonistic enzymes, histone acetyltransferases (HATs)
and histone deacetylases (HDACs), which transfer or
remove, respectively, an acetyl moiety of a lysine residue
mapping in the N-terminal tail of nucleosomal histones7.
Consequently, histone acetylation leads to relaxation of
chromatin structure eliciting onset of gene transcription,
while histone deacetylation induces a transcriptionally
repressed chromatin. The HAT enzymes, CREB-binding
protein (CBP) and p300, are essential for normal neuronal
development illustrated by early embryonic lethality of
CBP/p300 knockout mice and their link to neurodevelopmental disorders2,8. In neurons, the HAT/HDAC enzymes
also target non-histone proteins, such as transcription
factors and cytoskeletal proteins, thereby modulating gene
expression and microtubule-based organelle transport9,10.
Pharmacological manipulation of HDAC activities using
pan-HDAC inhibitors (HDACis), such as sodium butyrate
(NaBt), trichostatin A (TSA), and valproic acid (VPA)
induces neuronal differentiation of embryonic or adult
neural progenitors at the expanse of glial differentiation11,12. Given that they ameliorate neuronal differentiation and survival in various experimental mouse
models for neurodevelopmental disorders, they are
potential therapeutic tools for central nervous system
disorders13,14. However, our knowledge about their
mechanism of action remains limited. They are known to
promote neuronal differentiation by stimulating the
expression of cell cycle inhibitors and neurogenic basic
helix-loop-helix (bHLH) transcription factors, such as
Ngn-1, MATH-1, and NeuroD11,12.
Given our previous ﬁndings of a direct link between the
mitochondrial mass and NeuroD6 during the early stages
of neuronal differentiation15–17, we asked whether NaBt
could enhance neuronal differentiation by stimulating
mitochondrial biogenesis and inducing a metabolic shift
toward oxidative phosphorylation (OXPHOS). We used
our engineered neuroprogenitor-like PC12-NeuroD6 cells
(hereafter referred to as PC12-ND6) and E17.5 hippocampal neurons expressing high levels of NeuroD618.
Embryonic NeuroD6 expression is triggered at a time
when neuronal progenitor cells undergo cell cycle withdrawal and initiate neuronal glutamatergic differentiation
in the cortex and hippocampus19. NeuroD6 restricts the
proliferation potential of committed neural progenitors
during neurogenesis19–21.
In this study, we provide evidence for a novel developmental epigenetic layer coupling mitochondrial biogenesis
to neuronal differentiation. NaBt induces mitochondrial
biogenesis and enhances the oxidative metabolism in neural
progenitor cells. NaBt adapts mitochondrial morphology to
Ofﬁcial journal of the Cell Death Differentiation Association
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maximize mitochondrial respiratory activity generated by
OXPHOS. Our results demonstrate that epigenetic modulation of the mitochondrial pool prior to neurotrophic
signaling dictates the efﬁciency of initiation of neuronal
differentiation during the transition from progenitor to
differentiating neuronal cells. CBP modulates the mitochondrial biomass in neuronal precursor cells, conﬁrming
the NaBt-mediated regulation of mitochondrial mass.
Finally, our genome-wide analysis of the epigenetic mark
H3K27ac associated with active transcription shows that
NaBt induces histone acetylation in several interconnected
nodes of nuclear-encoded genes involved in neuronal differentiation and mitochondrial reprogramming.

Results
NaBt increases the mitochondrial biomass in neuronal
progenitor-like PC12-ND6 cells and E17.5 hippocampal
neurons

To test whether NaBt could modulate the mitochondrial mass in a neuronal context, we used our in vitro
neuronal cellular paradigm, PC12-ND6 cells and E17.5
hippocampal neurons, both recapitulating the early stages
of neuronal differentiation22. We established the optimal
NaBt concentration for PC12-ND6 cells (5 mM) and
E17.5 hippocampal neurons (2 mM) to induce maximal
acetylation levels with minimal cellular toxicity, and
showed that NaBt preferentially acetylated the lysine
residues of the histone H3 at positions 9 and 27 (Fig. S1).
We also conﬁrmed that 2 mM of NaBt triggers differentiation of E17.5 hippocampal neurons (Fig. S2A, B), in
keeping with VPA-mediated differentiation of adult
neural stem cells11,12.
We investigated whether NaBt could modulate the
mitochondrial mass in PC12-ND6 cell and E17.5 neurons.
Live-cell confocal microscopy revealed increased mitochondrial mass in NaBt-treated PC12-ND6 cells, which
was quantiﬁed to a twofold increase by ﬂow cytometry
(Fig. 1a, b). NaBt induced an elongated mitochondrial
morphology, which was conﬁrmed by transmission electron microscopy revealing cristae remodeling with tightly
stacked elongated cristae and reduced intercristae space
(Fig. 1a, c, d). NaBt also increased the mitochondrial
population in E17.5 hippocampal neurons by a 2.5 fold
(Fig. 1f). While control E17.5 neurons have short rod-like
mitochondria, NaBt-treated neurons harbor elongated
mitochondria (Fig. 1e), an effect sustained up to 8 DIV
(Fig. S2D). These results show that NaBt increases the
mitochondrial population and triggers mitochondrial
ultrastructural changes in progenitor neuronal cells.
NaBt enhances the population of bioenergetic
mitochondria and OXPHOS metabolism in PC12-ND6 cells

We assessed whether NaBt could enhance mitochondrial bioenergetics in PC12-ND6 cells using the
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Fig. 1 Sodium butyrate modulates the mitochondrial mass and mitochondrial microarchitecture in neuronal progenitor cells. a
Representative live-cell confocal micrographs of PC12-ND6 cells transfected with the vector mito-GFP to visualize mitochondria in the absence or
presence of NaBt (5 mM; 3 d). b Flow cytometry proﬁles of control and NaBt-treated PC12-ND6 cells stained with MitoTracker Green (MTG) and
quantiﬁcation of the ﬂuorescence intensity of labeled control and NaBt-treated PC12-ND6 cells. c Representative electron micrographs of
mitochondria in control (upper panel) and NaBt-treated (lower panel) PC12-ND6 cells (scale bar = 100 nm). d Quantiﬁcation of average mitochondrial
length (left panel) and distribution of mitochondrial lengths (right panel) in control and NaBt-treated PC12-ND6 cells. e Representative live-cell
confocal analysis of the mitochondrial biomass of untreated and NaBt-treated E17.5 hippocampal neurons transfected with the vector mito-GFP at 3
DIV (scale bar = 5 µm). f Left panel showing confocal micrographs of control and NaBt-treated E17.5 hippocampal neurons at 3 DIV and stage 3
labeled with the pan-neuronal marker β-III tubulin (red), the mitochondrial marker COXVα (green), and the nuclear counterstain DAPI (blue). Scale bar
= 5 µm. Right panel showing quantiﬁcation of the percent of cell volume occupied by mitochondrial volume using stacked confocal images and
Volocity software. All graphs are presented as mean ± S.D. *p ≤ 0.05 by t-test (n = 3)
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Fig. 2 Sodium butyrate augments the mitochondrial bioenergetic capacity of PC12-ND6 cells. a Left panel showing ﬂow cytometry proﬁles of
control and NaBt-treated PC12-ND6 cells stained with MitoTracker Red (MTR) and right panel showing the quantiﬁcation of the ﬂuorescence intensity
of labeled control and NaBt-treated PC12-ND6 cells stained with MTR. b Representative live-cell confocal micrograph of control and NaBt-treated
PC12-ND6 cells staining with the TMRM dye to assess the mitochondrial membrane potential. Scale bar = 20 µm. c Left panel showing the ﬂow
cytometry analysis of the mitochondrial membrane potential in control and NaBt-treated PC12-ND6 cells stained with TMRM and the right panel
showing the quantiﬁcation of the TMRM ﬂuorescence intensity. d The left panel shows a representative proﬁle of oxygen consumption rate (OCR)
from the mitochondrial stress test on duplicates from each cell type. The control and NaBt-treated PC12-ND6 cells are indicated in blue and red,
respectively. The drugs added throughout the test are indicated on top of the graph, as described in Materials and methods. The middle panel shows
a representative proﬁle of extracellular acidiﬁcation rate (ECAR) from the glycolytic function of the mitochondrial stress test. The left panel shows the
overall cell phenotype proﬁle from control (blue) and NaBt-treated PC12-ND6 cells (red). e Quantiﬁcation of individual parameters for basal OCR, ATPlinked respiration, maximal OCR, and spare respiratory capacity. Results are from three independent experiments each using duplicate samples. All
graphs are presented as mean ± S.D. *p ≤ 0.05 by t-test (n = 3)

mitochondrial dyes MTR and MTG. While MTG solely
stains mitochondria independently of the mitochondrial
membrane potential (ΔΨm), MTR labels energized mitochondria owing to its ΔΨm-dependent retention in the
mitochondrial matrix15. Flow cytometry analysis reveals a
3.5-fold and twofold increase in MTR and MTG signal,
respectively (Fig. 2a), suggestive of increased ΔΨm by
Ofﬁcial journal of the Cell Death Differentiation Association

NaBt. This was corroborated with the dye tetramethylrhodamine methyl ester (TMRM), which accummulates in the mitochondrial matrix in a ΔΨm-dependent
fashion17. NaBt increases the TMRM signal by a 1.5 fold
(Fig. 2b, c). We ruled out that NaBt increased ROS levels
as a consequence of increased mitochondrial bioenergetics using the MitoSOX™ dye (Fig. S3).
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These results led us to speculate that NaBt stimulates
the OXPHOS metabolism. Using the Seahorse technology, we investigated the NaBt effect on the metabolic
potential of PC12-ND6 cells by assessing mitochondrial
OXPHOS and glycolysis. NaBt-treated cells exhibited
increased mitochondrial respiration while glycolysis
remained unchanged (Fig. 2d). We next measured key
bioenergetic parameters of the OXPHOS pathway and
found that the basal oxygen consumption rate (OCR) of
NaBt-treated PC12-ND6 cells increased by 78% when
compared to that of control PC12-ND6 cells (Fig. 2d, e).
By exposing the cells to oligomycin A, an inhibitor of the
ATP synthase, we detected a 56% increase in ATP-linked
respiration in the presence of NaBt (Fig. 2d, e), in keeping
with the increased ΔΨm (Fig. 2b, c). Using the uncoupler
FCCP, we found that NaBt increased maximal and spare
respiratory capacities by 115 and 145%, respectively,
(Fig. 2d, e). NaBt-treated cells exhibited an FCCPmediated increase in ECAR followed by a decreased
ECAR triggered by antimycin A, consistent with respiratory acidiﬁcation from increased tricarboxylic acid (TCA)
cycle activities, resulting in greater CO2 levels (Fig. 2d).
Thus, our bioenergetic results supports our confocal
microscopy and ﬂow cytometry analyses, revealing the
ability of NaBt to generate a reserve of bioenergetically
competent mitochondria with enhanced OXPHOS
metabolism.
NaBt induces mitochondrial biogenesis in PC12-ND6 cells

In view of NaBt-mediated increase in mitochondrial
population, we hypothesized that NaBt may induce
mitochondrial biogenesis via mitochondrial DNA (mtDNA) metabolism. Live-cell confocal microscopy reveals
increased number and size of mt-nucleoids in NaBttreated cells, while mt-nucleoids are barely detectable in
control cells (Fig. 3a). By qPCR, we detected a 2.9-fold
increase of mt-DNA copy number in NaBt-treated cells
(Fig. 3b), in keeping with the twofold increase in mitochondrial mass. Other pan-HDACis, TSA, VPA, and
BML-210, also increased mt-DNA copy number, suggestive of a common mechanism to stimulate mt-DNA
metabolism (Fig. 3b).
We examined the expression levels of the nuclearencoded TFAM protein since its levels are directly proportional to mt-DNA copy number23. Immunoblot analysis shows a twofold increase in TFAM levels after 2 days
of NaBt treatment, which was conﬁrmed by immunocytochemistry (Fig. 3c, d). Since the nuclear respiratory
factor 1 (NRF-1) regulates the Tfam promoter activity and
maintains mt-DNA copy number in vivo24,25, we assessed
its expression pattern and found increased NRF-1 levels
preceding those of TFAM in NaBt-treated cells (Fig. 3e).
Finally, we examined the transcriptional coactivator PGC1α, a nodal regulator of mitochondrial biogenesis in many
Ofﬁcial journal of the Cell Death Differentiation Association
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cell lineages26, and found no increased expression in
treated cells (Fig. 3f). This is not surprising given that
NaBt in part mimics PGC1α by recruiting HATs to the
NRF-1 and Tfam promoters27. These results indicate that
NaBt induces mitochondrial biogenesis and mt-DNA
replication via the NRF-1–TFAM axis.
The timing of NaBt treatment is critical for potentiating
sub-optimal neurotrophic cues

Given that NaBt-stimulated mitochondrial biogenesis
and bioenergetics, we explored whether NaBt could
potentiate sub-optimal neurotrophic cues in PC12-ND6
cells and whether a temporal window for NaBt responsiveness could be critical to elicit effective neurite outgrowth. We used the dbcAMP experimental paradigm,
since it elicits limited neuritogenesis in PC12 cells21,28.
Pre-NaBt treatment potentiated the neuritogenic activity
of dbcAMP in a dose-dependent manner (Fig. 4a, b) by
promoting extensive neurite outgrowth after 5 days of
dbcAMP exposure, a response that dbcAMP alone could
not trigger (Fig. S4A). In contrast, co-treatment with NaBt
and dbcAMP severely dampened the NaBt effect on
increased neuritogenesis (Fig. 4a, b), suggesting that
acquisition of adequate mitochondrial mass precedes
onset of neuritogenesis.
We examined the NaBt effect on PC12-ND6 neuronal
competency using sub-optimal NGF concentration. PreNaBt-treated cells showed accelerated neuritogenesis,
whereas control cells displayed a reduced neuritogenesis
(Fig. 4c, d). Pre-NaBt treatment also altered the frequency
of maximal neurite length triggered by NGF (Fig. 4e), an
effect maintained for 3 days (Fig. S4B). No synergistic
effect was detected in co-treated cells (Fig. 4e), in keeping
with the curtailed effect of co-administering NaBt and
dbcAMP (Fig. 4b). Thus, our results indicate that the
timing of NaBt exposure is critical to potentiate suboptimal levels of neurotrophic factors.
NaBt promotes the acquisition of a critical pool of
mitochondria to ensure efﬁcient neuritogenesis

In view of the temporal window of NaBt-mediated
responsiveness to neurotrophic factors, we hypothesized
that induction of mitochondrial biogenesis may be a critical step of the neuronal differentiation program. We
modulated the mitochondrial mass by blocking or stimulating mitochondrial biogenesis with chloramphenicol
(Cm) or NaBt, respectively. Cm selectively inhibits mitochondrial translation without interfering with translation
of nuclear-encoded proteins29. We ﬁrst conﬁrmed that
Cm did not affect cell viability (Fig. 5a). To assess the
efﬁcacy of Cm treatment, we measured the expression
levels of the nuclear-encoded succinate dehydrogenase
(SDH-A) subunit of Complex II and the mitochondrialencoded subunit I of Complex IV (MT-COI). While SDH-
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Fig. 3 (See legend on next page.)

Ofﬁcial journal of the Cell Death Differentiation Association

Page 6 of 18

Uittenbogaard et al. Cell Death and Disease (2018)9:360

Page 7 of 18

Fig. 3 Sodium butyrate stimulates mitochondrial biogenesis in PC12-ND6 cells by increasing mt-DNA copy number and expression levels
of key regulators of mt-DNA replication. a Representative live-cell confocal micrograph of PicoGreen staining of mt-nucleoids in control and NaBttreated PC12-ND6 cells transfected with the mito-RFP vector. Scale bar = 5 µm. b Quantiﬁcation of Mt-DNA copy number by qPCR from control and
HDACi-treated PC12-ND6 cells and normalized by ΔΔC(t). Mean ± SEM (n = 3; *p < 0.001). c Upper panel illustrating quantitative immunoblot analysis
of TFAM expression in control and NaBt-treated PC12-ND6 cells. Lower panel showing the graphed TFAM/GAPDH ratio normalized to untreated
PC12-ND6 cells. Mean ± SEM (n = 3; *p ≤ 0.05). d Representative confocal micrographs of control and NaBt-treated PC12-ND6 cells stained for
mitochondrial-speciﬁc transcriptional factor TFAM (green), mt-DNA (red), and the nuclear counterstain DAPI (blue). Scale bar = 5 µm. e Left panel
illustrating the quantitative immunoblot analysis of NRF-1 expression in control and NaBt-treated PC12-ND6 cells. Right panel showing the graphed
NRF-1/GAPDH ratio normalized to control PC12-ND6 cells. Mean ± SEM (n = 3; *p ≤ 0.05). f Left panel illustrating the quantitative immunoblot analysis
of PGC1-α in control PC12 and PC12-ND6 cells as well as NaBt-treated PC12-ND6 cells. Right panel showing the graphed PGC1-α/GAPDH ratio
normalized to control PC12 cells. Mean ± SEM (n = 3)

Fig. 4 The timing of NaBt treatment is critical for enhancing neuronal differentiation of PC12-ND6 cells upon sub-optimal neurotrophic
cues. a Representative confocal micrographs of PC12-ND6 cells transfected with the mito-GFP vector and treated with dbcAMP alone (left panel) or
with NaBt in a simultaneous (middle panel) or sequential (right panel) manner. Scale bar = 5 µm. b Graph of neurite length for each experiemental
condition. Mean ± SEM (n = 50 for each condition; compared to control; *p ≤ 0.0001). c Representative confocal micrographs of PC12-ND6 cells
transfected with the mito-GFP vector and treated with sub-optimal NGF concentration (10 ng/ml) alone (left panel) or ﬁrst NaBt (5 mM) in a
simultaneous (middle panel) or sequential (right panel) manner. Scale bar = 10 µm. d Graph of average total neurite length for each experimental
condition. Mean ± SEM (n = 50 for each condition; compared to control; *p ≤ 0.0001). e Graph of the frequency of total neurite length below and
above 90 µm for each experimental condition
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Fig. 5 (See legend on next page.)
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Fig. 5 Pre-treatment of PC12-ND6 with NaBt cells negates the inhibitory effect of chloramphenicol on neuronal differentiation. a
Quantiﬁcation of PC12-ND6 cell death upon exposure to different concentrations of chloramphenicol (Cm). Data are expressed as percent of cell
death ± SEM (n = 250 cells). b Left panel showing quantitative immunoblot analysis of mitochondrial-encoded MT-COI protein (green) and nuclearencoded SDH-A protein (red) in untreated and Cm-treated PC12-ND6 cells. Right panel showing quantiﬁcation of the ratio MT-COI/SDH-A normalized
to untreated PC12-ND6 cells. Data are expressed as mean ± SEM (n = 3; compared to untreated cells; *p = 0.0052; **p = 0.0048; ***p = 0.0034). c
Representative live confocal micrographs of untreated and Cm-treated PC12-ND6 cells transfected with the vector mito-GFP (left panels) and of NaBt
pre-treated PC12-ND76 cells transfected with the vector mito-GFP prior to vehicle or Cm exposure (right panel). Scale bar = 5 µm. d Representative
live confocal micrographs of PC12-ND6 cells transfected with the vector mito-GFP and treated with Cm (2 d) followed by NGF exposure for 3 days
(left panel) and NaBt pre-treated PC12-ND6 cells transfected with the vector mito-GFP before being exposed to Cm (2 d) followed by 3 days of NGF
treatment (middle panel). Scale bar = 20 µm. Right panel showing quantiﬁcation of average total neurite length for each experimental conditions.
Data are expressed in mean ± SEM (n = 50 cells; compared to untreated PC12-ND6 cells *p = 0.0001; compared to non-NaBt-treated PC12-ND6 cells
with corresponding Cm concentration **p = 0.0001). e The left panel shows representative confocal micrographs of E17.5 hippocampal neurons in
the absence or presence of Cm (60 µM) at 2 DIV and labeled with anti β-III tubulin antibody (red) and nuclear counterstain DAPI (blue) at 3 DIV (top
row) and of confocal micrographs of e17.5 hippocampal neurons treated with NaBt (2 mM) at 1 DIV prior to exposure to Cm (60 µM) at 2 DIV and
labeled with anti β-III tubulin antibody (red) and nuclear counterstain DAPI (blue) at 3 DIV (bottom row). Scale bar represents 10 µm. The right panel
shows the quantiﬁcation of E17.5 β-III+ hippocampal neurons at the neuronal stage 3. Data are expressed as mean ± S.D. (n = 250 cells; compared to
untreated control *p = 0.0001; compared to the corresponding non-NaBt-treated sample **p = 0.0001; compared to non-NaBt-treated cells exposed
to Cm at 30 µM ‡p = 0.007)

A expression remained unaltered by Cm, MT-COI
expression was abolished at the lowest Cm dose
(Fig. 5b). Live-cell confocal microscopy conﬁrms
decreased mitochondrial mass in Cm-treated cells, while
pre-NaBt-treated cells sustain their mitochondrial biomass even at high Cm doses (Fig. 5c).
To test whether a critical mitochondrial mass is
required for optimal neuritogenesis, we treated PC12ND6 cells with NaBt before a 2-day Cm treatment followed by a 3-day NGF exposure. Low Cm dose reduced
total neurite length by 43%, while pre-NaBt treatment
optimized neuritogenesis with a sustained mitochondrial
density despite high Cm concentration (Fig. 5d). Similarly,
Cm treatment of E17.5 hippocampal neurons without
NaBt pre-exposure hampered the frequency of stage 3,
while NaBt pre-treatment insured a normal progression
to stage 3 (Fig. 5e). Thus, acquisition of a critical pool of
mitochondrial mediated by NaBt prior to neurotrophic
cues is a fundamental step that dictates the efﬁciency of
neuritogenesis and progression of neuronal differentiation. Mitochondrial biogenesis is an integral component
of the epigenetic-induced neuronal differentiation
program.
The HAT CBP modulates the mitochondrial biomass in
PC12-ND6 cells

Since the chromatin modiﬁer CBP regulates differentiation of neuronal precursors via its HAT activity2, we
investigated whether CBP could modulate the mitochondrial biomass of PC12-ND6 cells. We showed that
NaBt increased the levels of CBP expression by a 2.5-fold
in PC12-ND6 cells (Fig. 6a), consistent with TSAmediated rescue of CBP-knockdown in precursor neurons2. We knockdowned cbp expression using shRNA to
assess its effect on the mitochondrial population. We
Ofﬁcial journal of the Cell Death Differentiation Association

detected a 2.8-fold decrease of the mitochondrial population and an altered mitochondrial morphology with a
preponderance of swollen mitochondria, suggesting
defective mitochondrial dynamics (Fig. 6b, c). Conversely,
CBP overexpression augmented the mitochondrial
population by twofold (Fig. 6b, c), comparable to that of
the NaBt treatment (Fig. 1b). Thus, our genetic-based
analysis conﬁrms our NaBt results and shows that CBP
modulates the mitochondrial biomass in PC12-ND6 cells.
NaBt generates an epigenetic signature in complementary
nodes of nuclear-encoded genes regulating neuronal
differentiation and mitochondrial reprogramming

We performed ChIP assays followed by genome-wide
deep-sequencing (ChIP-seq) by interrogating the
H3K27ac signature, a hallmark of active enhancers. We
opted for a 3-day NaBt treatment to concomitantly capture gene networks controlling neuronal differentiation
and mitochondrial reprogramming. ChIP-seq assays were
performed on two independent replicates from control
and NaBt-treated cells. The H3K27ac peaksets were
highly reproducible between biological replicates, with the
PCA analysis conﬁrming the existence of two separate
groups of differential binding (DB) sites (Fig. S5). The MA
plot indicates 3857 DB sites with at least a two-fold
change and a FDR < 0.05, 2281 DB in NaBt-treated cells
and 1548 in control cells (Fig. 7a). The box plots of read
distributions conﬁrms increased afﬁnity in NaBt-treated
cells when comparing the higher median in the ( + )
column of treated cells with that of the (−) column of
control cells (Fig. 7b). 25% of DB sites mapped in promoter regions, while 31 and 43% of DB sites were located
within genic and intergenic regions, respectively (Fig. 7c).
Using Venny30 on DB sites with at least a two-fold change,
a p-value < 0.05, and a FDR < 0.05, we found that nearly
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Fig. 6 The HAT CBP modulates the mitochondrial biomass in PC12-ND6 cells. a Quantitative immunoblot analysis of CBP expression in control
and NaBt-treated PC12-ND6 cells. Lower panel showing the graphed CBP/GAPDH ratio normalized to untreated PC12-ND6 cells and presented as
mean ± SEM (n = 3; *p = 0.04; **p = 0.0001). b Representative live confocal micrographs of PC12-ND6 cells transfected with the pRFP-C-RS ratSH
shRNA turboRFP vector containining either the negative control shRNA-scrambled #15, speciﬁc shRNA-CBP #77, or the CBP overexpressing pRc/RSVmCBP-HA vector before staining with the MTG dye (scale bar = 10 µm). The insets show a high magniﬁcation of mitochondria to illustrate their
morphology for each condition. c Quantiﬁcation of mitochondrial integrated density per cell area using stacked confocal images and Image J.
Graphed data are presented as mean ± SEM (n = 3 experiments for each condition; *p ≤ 0.05)

41% of the DB sites mapped in the TSS, promoter, exons
and introns regions of 903 genes, while very few peaks
were speciﬁc to a single genomic region (Fig. 7d). The
promoter region was deﬁned as ±1 Kbp of the TSS, while
the TSS region was demarcated by a peak overlapping the
actual TSS. Given the considerable overlap between these
two annotations (Fig. 7d), subsequent analyses were performed on the 1099 DB sites mapping in 989 promoter
regions (Table S1).
Using PANTHER31, gene ontology analysis reveals gene
enrichment in the GO cellular and metabolic processes,
which share genes involved in neurotrophic response,
chromatin organization, mitochondrial homeostasis, and
energy metabolism (Fig. 7e). Similarly, the reactome
pathway analysis shows several nodes for developmental
biology, organelle biogenesis, chromatin organization, and
mitochondrial translation with signiﬁcant p-values and
gene counts (Fig. 7f). Using STRING database, we identiﬁed enriched DB sites in many neuronal genes, 15 of
those involved in axon guidance with high level of connectivity (Fig. 7g). It also reveals enrichment in 14 genes
encoding mitochondrial ribosomal proteins (MRPs)
(Fig. 6h), which are integral components of mitochondrial
Ofﬁcial journal of the Cell Death Differentiation Association

ribosomes responsible for translation of the 13
mitochondrial-encoded OXPHOS proteins32. Except for
the MRPL36 promoter, the ChIP-seq results indicate a
slight decrease in number of reads for 13 MRPs in NaBttreated cells (Table S1). This trend is consistent with our
immunoblot kinetic results showing increased expression
of the NRF-1 and TFAM regulators of mitochondrial
biogenesis, during its initial surge during the ﬁrst 2 days of
NaBt treatment, whereas its maintenance more likely
occurs at day 3 (Fig. 3c, f). Among the 1099 DB sites, we
found 55 DB sites exhibiting a unique H3K27ac signature
with high amounts of reads in NaBt-treated cells and
barely any reads in control cells, all of them involved in
cytoskeletal remodeling, synaptic activity and mitochondrial metabolism (Table S2). Our ChIP-qPCR validation
analysis on ﬁve of those genes, Ajuba, Lgals3, Synpo,
Slc35f6, and Gstm2, shows NaBt-mediated enrichment of
H3K27ac mapping in their promoters in accordance with
the ChIP-seq results (Fig. 7i).

Discussion
In this study, we report a novel developmental epigenetic layer that couples mitochondrial biogenesis to
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Fig. 7 (See legend on next page.)
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Fig. 7 Genome-wide analysis of H3K27 acetylation in control and NaBt-treated PC12-ND6 cells. a MA plot of control (untreated) and NaBttreated PC12-ND6 cells The 3857 differential bound (DB) sites are shown in red (FDR < 0.050). b Box plots of read distributions for signiﬁcantly DB
sites. The left two boxes show distribution of reads over all DB sites in the control and NaBt-treated groups; the middle two boxes show distributions
of reads in DB sites that increase in afﬁnity in the NaBt group ( + ); the last two boxes show distributions of reads in DB sites that increase in afﬁnity in
the control group (−). c Distribution of DB H3K27ac sites with respect to intragenic regions including promoter, introns, and exons, and intergenic
regions. d Venn diagram of unique and overlapping DB H3K27ac sites in different genomic regions. e Gene ontology analysis by PANTHER with
percent distribution of the DB sites in the identiﬁed biological processes. f Dot-plot graph of the Reactome pathway enrichment analysis for the DB
sites with the corresponding p-values and count indicated for each pathway. g In silico networking among the 15 identiﬁed neuronal genes with
high H3K27ac levels using STRING database. The red circles with thick black borders identify genes from the ChIP-seq analysis with NaBt-mediated
increased levels of H3K27ac that are integrated within three neuronal GO processes: axon guidance, signal transduction, and cellular differentiation,
while the yellow circles indicate genes with increased H3K27ac that are not interconnected within these three GO processes. The red circles indicate
members of this neuronal pathway that were not revealed by the ChIP-seq analysis. The thickness of connectors represents the edge conﬁdence of a
given interaction, with a minimum score of 0.9 for thick lines, a minimum score of 0.70 for medium lines, and a minimum of 0.4 score for light lines. h
In silico networking among the 14 identiﬁed MRPs with high H3K27ac levels using STRING database. The blue and orange circles illustrate the small
and large subunits of MRPs, respectively. The thickness of connectors represents the edge conﬁdence of a given interaction, as described in g. i ChIPqPCR validation of the six genes exhibiting enriched H3K27ac in the presence of NaBt using either a H3K27ac-speciﬁc antibody or immunoglobulin G
control (gray) and ChIP reactions from control (red) or NaBt-treated PC12-ND6 (blue) cells. Data are expressed in % input and mean ± S.D. from n = 2.
*p < 0.05

neuronal differentiation. Modulation of the mitochondrial
biomass using gain- and loss-of-function-like pharmacological assays has exposed the timing of mitochondrial
biogenesis as a key event to enhance neuronal progenitor
competency to differentiate. Our collective results
demonstrate that epigenetic regulation of mitochondrial
reprogramming is an integral component of the overall
epigenetic signature induced by neurotrophic signaling in
preparation for upcoming energy needs associated with
neuronal differentiation. CBP regulates the mitochondrial
biomass, congruent with its role as a regulator of neural
precursor competency via its HAT activity2. Given that
half of the mitochondrial proteome is tissue-speciﬁc33,
epigenetic regulation of mitochondrial biogenesis and
bioenergetics provides a mechanistic layer to tailor and
synchronize the mitochondrial proteome to a speciﬁc
cellular and developmental context. NaBt confers an
H3K27ac epigenetic signature in several nodes of nuclear
genes promoting neuronal differentiation and mitochondrial reprogramming. Our ﬁndings add a new facet to the
mechanistic understanding of how pan-HDACis induce
differentiation of neuronal progenitor cells, thereby
extending previous studies that only characterized the
molecular events coordinating neuronal differentiation to
cell cycle exit via upregulation of NeuroD and the CDKi
p21WAF/cip111,12. Increased mt-DNA replication by four
pan-HDACis suggests a common mechanism by which
they regulate mitochondrial biogenesis.
Until recently, little emphasis has been placed on the
neuronal-speciﬁc regulation of mitochondrial biogenesis.
We previously reported NeuroD6 promoting mitochondrial biogenesis at the outset of neuronal differentiation
via the NRF-1/TFAM axis15–17. Increased mitochondrial
biogenesis via Tfam expression was also reported in ES
cells and progenitor-like cells undergoing neuronal
Ofﬁcial journal of the Cell Death Differentiation Association

differentiation upon retinoic acid treatment34,35. Exposure
of embryonic hippocampal neurons to the morphogen
Sonic Hedgehog increases mitochondrial mass during
axonal outgrowth36,37, while activation of mitochondrial
biogenesis in embryonic cortical neurons coincides with
neuritogenesis38,39.
Our ﬁndings extend those previous studies by identifying a novel epigenetic regulatory layer that synchronizes
the timing of mitochondrial reprograming with
neurotrophin-induced differentiation. Our gain-and lossof-function results reveal mitochondrial biogenesis as a
critical preparatory step for induction of differentiation.
NaBt-mediated increase of TFAM expression and mtDNA copy number is physiologically pertinent, as TFAM
is a limiting determinant of mt-DNA copy number and
essential for in vivo mitochondrial biogenesis. While
embryonic disruption of the Tfam gene triggers early
embryonic lethality due to a lack of mt-DNA and severe
OXPHOS deﬁciency, Tfam postnatal disruption in hippocampal neurons decreases mt-DNA copy number and
OXPHOS capacity leading to axonal degeneration23,40.
Conversely, Tfam transgenic mice harbor increased mtDNA copy number41.
Epigenetic regulation of mitochondrial reprogramming
is congruent with the requirement of a speciﬁc landscape
of histone acetylation for neuronal lineage progression1,2,4. Our results evoke a NeuroD6–CBP interplay
coordinating epigenetic status, mitochondrial biogenesis
and neuronal differentiation15,16. NeuroD6 expression is
regulated by the transcription factor C/EBPβ, which
favors neurogenesis by sequestering CBP from STAT to
activate neuronal genes42,43. Our Ajuba ChIP-seq and
ChIP-qPCR results substantiate our model of epigenetic
regulation synchronizing neuronal differentiation and
mitochondrial reprogramming. Ajuba increases histone
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acetylation by recruiting CBP to PPARγ, thereby activating expression of PPARγ target genes, such as the C/EBP
transcription factors44. Thus, the Ajuba–CEBP interconnection can be viewed as a component of the
NeuroD6–CBP axis adapting mitochondrial biogenesis to
neuronal differentiation15,17,42.
Moreover, NaBt induces an H3K27ac epigenetic ﬁngerprint in the MRPs node, which is critical for mitochondrial biogenesis via their role in translation of
mitochondria-encoded OXPHOS subunits15,17,45. It is
clinically relevant, as mitochondrial respiratory neurodevelopmental disorders exhibit defective mitochondrial
biogenesis, mitochondrial protein synthesis, and
OXPHOS46. Mutations in the MRPL16, MRPL3, and
MRPL12 genes cause corpus callosum agenesia, psychomotor retardation, and neurological deterioration,
respectively47,48.
The validated genes, Lgals3 and synaptopodin, promote
axonal and dendritic outgrowth, respectively, which
depend on mitochondrial homeostasis. In hippocampal
and dorsal root ganglion neurons, Lgals3 induces axonal
branching via enrichment of F-actin branchlets at the site
of protrusive activity, a process requiring local stalling of
mitochondria and increased OXPHOS activity49,50. The
actin-binding protein synaptopodin modulates synaptic
activity of cortical and hippocampal neurons by promoting formation of dendritic spines and regulating local Ca2
+
levels, processes in which mitochondria are critical51,52.
Epigenetic regulation also coordinates changes in
mitochondrial ultrastructure with enhanced OXPHOS
metabolism. This is particularly relevant for mitochondrial biogenesis, which requires maintenance of the
mitochondrial membrane potential for importing nuclearencoded proteins involved in diverse mitochondrial
functions, such as OXPHOS, mtDNA replication and
transcription, mitochondrial dynamics and membrane
biogenesis46. The validated Slc35f6 gene stimulates ΔΨm
by interacting with the mitochondrial ATP transporter
ANT2 embedded in the mitochondrial inner membrane
to transport ATP out to the cytosol while importing ADP
into the mitochondrial matrix53,54. Our ChIP-seq results
corroborate the NeuroD6-mediated synchronization of
enhanced ΔΨm and mitochondrial biogenesis with onset
of neuronal differentiation17, which was also reported in
neuroblasts and axons of NGF-treated sensory
neurons55,56.
Epigenetic regulation calibrates metabolic functions to
match high energetic demand during the onset of neuronal differentiation by increasing maximal mitochondrial
respiration activity and generating considerable spare
respiratory capacity to confer resistance to oxidative stress
and excitotoxicity during differentiation. This is consistent with NeuroD6 mitigating ROS levels generated by
increased OXPHOS activities in neuronal precursors, and
Ofﬁcial journal of the Cell Death Differentiation Association
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Fig. 8 Working model on the coordinated epigenetic regulation
of mitochondrial biogenesis and neuronal differentiation. The
HDACi NaBt in part recapitulates the epigenetic regulation induced by
neurotrophic signaling in which the CBP chromatin modiﬁer regulates
the mitochondrial mass in differentiating neuronal precursor cells.
Epigenetic regulation modulates the mitonuclear crosstalk via the
anterograde and retrograde sinaling to synchronize the two distinct
genomes

increased mitochondrial bioenergetics in embryonic cortical neurons and neural progenitor cells derived from
iPSCs17,38,57,58.
In summary, our ﬁndings lend support to our working
model whereby epigenetic regulation dynamically synchronizes the mitochondrial and neuronal programs for
efﬁcient neuronal differentiation (Fig. 8). NaBt in part
recapitulates neurotrophic signaling by generating an
H3K27ac signature promoting these two programs, with
CBP playing a key role in modulating the mitochondrial
mass. Epigenetic regulation also inﬂuences the
mitochondrial–nuclear crosstalk by coordinating gene
expression from these two distinct genomes via anterograde and retrograde signaling with mitochondria producing the acetyl moiety for histone acetylation of nuclear
genes. Future studies will elucidate the HDACis-mediated
comprehensive epigenetic signature of these programs to
set the stage for investigations in the context of metabolic
and neurodegenerative diseases with mitochondrial
dysfunctions.

Materials and methods
Preparation of embryonic E17.5 hippocampal neurons and
transfection

E17.5 hippocampal neuron cultures were prepared as
described59. All animal procedures were carried in compliance with the Institutional Animal Care and Use
Committee. Brieﬂy, hippocampi were dissected from
E17.5 mouse fetuses in ice-cold Hanks balanced salt
solution (HBSS) modiﬁed (Hyclone). Isolated hippocampi
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were digested with 20 U/ml of papain (Worthington) and
2000 U/ml DNase1 (Worthington) at 37 °C for 60 min
before being triturated with a 10 ml pipette. Cells were
centrifuged at 900 rpm for 5 min and washed with HBSS.
Neurons were resuspended in DMEM supplemented with
10% fetal bovine serum and penicillin/streptomycin
before being plated at a concentration of 3 × 105 cells on
35 mm2 glass-bottom plates (Warners Instruments)
coated with 0.01% poly-L-ornithine (Sigma). In experiments using neurons transfected with the mito-GFP
vector (1 µg; Clontech), the Amaxa nucleofector system
was used according to the manufacturer’s recommendations (Lonza) and dissociated neurons were transfected
prior to plating, as described above. After incubation in a
5% CO2 incubator at 37 °C overnight, neurons were then
switched to Neurobasal medium containing 2 mM glutamine, B27, 10 ng/ml hFGF and penicillin/streptomycin.
All reagents were purchased from Invitrogen, unless stated otherwise.
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recommendations. Live cells were identiﬁed by blue
ﬂuorescence (excitation: 350 nm; emission: 461 nm),
whereas dead cells were identiﬁed by red ﬂuorescence
(excitation: 571 nm; emission: 639 nm). The percent of
cell death was quantiﬁed using Image J software.
Quantitative immunoblot analysis

Whole cell extracts were isolated and resolved as
described57. Nitrocellulose membranes were probed with
various primary antibodies (Table S3) overnight, and then
incubated for 1 h with anti-mouse or anti-rabbit secondary antibody directly conjugated to a 680-nm or 800-nm
ﬂuorescent dye (LI-COR). Samples were simultaneously
normalized to an endogenous reference (GADPH).
Fluorescence signals were measured and quantiﬁed using
the Odyssey imaging system (LI-COR).
Immunocytochemistry

Immunocytochemistry was performed as described16
with primary and secondary antibodies listed in Table S3.

PC12-ND6 cell culture and transfection

PC12-ND6 cells were grown and transfected with the
mito-GFP or mito-RFP vector or the pRc/RSV-mCBP-HA
plasmid (Addgene) by electroporation (BTX, Harvard
Apparatus), as described17. For shRNA-based silencing of
CBP, we transfected PC12-ND6 cells with the pRFP-C-RS
ratSH shRNA turboRFP vectors (Origene, Rockville, MD
containing either the scrambled negative control shRNA
cassette (Cat # TR30015) or the rat CBP targeting shRNA
FI750477 (AAGACTGTGGAGGTCAAGCCAGGAATGAA) (Cat# TF712619). For immunocytochemistry, cells
were grown on poly-D-lysine (PDL)-coated coverslips. For
live cell confocal microscopy, cells were seeded onto 50
mm PDL-coated glass bottom plates (Warners
Instruments).
Drug treatment

PC12-ND6 cells and E17.5 hippocampal neurons were
exposed to different concentrations (2 mM, 5 mM, or 10
mM) of NaBt for indicated periods of time. PC12-ND6
cells were treated with VPA (1 mM), TSA (600 nM), or
BML-210 (10 µM) for 2 days, when indicated. PC12-ND6
cells were treated with dbcAMP (1 mM; Sigma) or NGF
(Roche Molecular Biochemicals) at 10 ng/ml or 100 ng/
ml. PC12-ND6 cells and E17.5 hippocampal neurons were
exposed to different concentrations (15, 30, and 60 µM) of
chloramphenicol (Sigma) for the indicated time period.
All HDACis, except BML-210 (Enzo Life Sciences), were
purchased from Sigma.
Cell viability assay

Cell viability was assessed by live-cell confocal microscopy using the Nuclear-ID™ Blue/Red viability assay
(Enzo Life Sciences) according to the manufacturer’s
Ofﬁcial journal of the Cell Death Differentiation Association

Confocal microscopy and quantiﬁcation of neurite length

For ﬁxed cells, images were acquired with a ×63 or
×100/1.46 oil immersion objective using the Zeiss LSM
710 confocal microscope. For live-cell confocal microscopy, cells were visualized with a 100×/1.46 oil immersion objective using the Zeiss LSM 510 confocal
microscope equipped with a TempModuleS and CO2
Module (Zeiss) to maintain the temperature and CO2
levels at 37 °C and 5.0%, respectively. Combined differential interference contrast (DIC) and ﬂuorescence confocal imaging were used to measure neurite length in
transfected live cells. Imaging was acquired with a z stack
to ensure that the full length of neurites is acquired.
Neurite length was measured on ﬁxed cells immunostained with an anti-β-III tubulin antibody (Table S1). The
function measurement of the Zen software (Zeiss) was
used and a neurite outgrowth threshold was set at the
diameter of cell body.
Quantiﬁcation of mitochondria in cultured E17.5
hippocampal neurons

E17.5 hippocampal neurons were grown in the absence or
presence of NaBt (2 mM) at 1 DIV, ﬁxed and permeabilized
at 3 DIV as described15. Differentiating neurons were
identiﬁed using an anti-βIII tubulin antibody (Table S1) and
mitochondria were labeled with an anti-COXVα antibody
(Table S1). All cells were counterstained with nuclear stain
DAPI. Confocal images were acquired using the Zeiss LSM
710 system and a ×100/1.46 oil immersion objective. Stack
images of neuronal cells at stage 3 were captured using the
optimal overlapping (50%) option from the Zen software to
insure complete stacking on 25 cells from two independent
experiments for each experimental condition. Cell and
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mitochondrial volumes were calculated using Volocity
(v5.0) software, as described53.
Labeling of mitochondrial nucleoids

PC12-ND6 cells were ﬁrst transfected with the mitoRFP vector (Clonetech) by electroporation and cultured in
the absence or presence of NaBt (5 mM) for 2 days.
Untreated and treated PC12-ND6 cells were incubated in
1 ml of serum-free medium containing 3 µl of the ﬂuorescent DNA dye PicoGreen® (Invitrogen) for 1 h at 37 °C.
Cells were washed with PBS and images were acquired by
live cell confocal microscopy in the presence of phenol
red-free medium using a ×100/1.46 objective.
Mitochondrial DNA content by quantitative PCR

Total cellular DNA from three independent samples of
untreated and NaBt-treated PC12-ND6 cells was isolated
by phenol-chloroform extraction using standard methods.
Mitochondrial DNA was quantiﬁed by normalizing the
mitochondrial-encoded gene COXI (mtco1) to the
nuclear-encoded gene Ndufv1 using qPCR and the ΔΔCT
method. Primers used in this study were: 5′ACCCCCTGCTATAACCCAATATCAGAC-3′
(F,
COXI), 5′-TGGGTGTCCGAAGAATCAAAATAG-3′ (R,
COXI), 5′-CGCCATGACTGGAGGTGAGGCAG-3′ (F,
Ndufv1), and 5′-GGCCCCGTAAACCCGATGTCTTC-3′
(R, Ndufv1). SYBR Green ﬂuorescence detection for qPCR
was performed using iCycler iQ Real-time Detection
System (Bio-Rad). A total of 10 ng total DNA was used in
a 25 µl reaction containing 1× SYBR Green iCycler iQ
mixture and 0.2 µM of forward and reverse gene-speciﬁc
primers. Data are expressed as mean ± SEM.
Measurement of mitochondrial mass by ﬂow cytometry

Untreated and NaBt-treated PC12-ND6 cells were
stained with either 50 nM Mitotracker® Red (MTR)
(chloromethyl-X-rosamine; Molecular Probes) or 70 nM
Mitotracker® Green (MTG; Molecular Probes) and analyzed with a FACScalibur ﬂow cytometer (BD Bioscience)
as described15. Data were collected from 20,000 cells for
each sample from three independent experiments.
Measurement of the mitochondrial membrane potential
(ΔΨm)

Cells were incubated with 25 nM TMRM (Invitrogen) at
37 °C for 45 min. ΔΨm was assessed by live confocal
ﬂuorescence microscopy, in the presence of diluted
TMRM (5 nM). ΔΨm was quantiﬁed by ﬂow cytometry
analysis using a FACScalibur ﬂow cytometer, as described57. Data were collected from 20,000 events for each
sample per experiment (n = 4) and analyzed using CellQuant software. Data were normalized against the
TMRM-emitted ﬂuorescence intensity of untreated PC12ND6 cells ±S.D.
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Page 15 of 18

Live cell measurement of mitochondrial respiration

Bioenergetic status was measured using the Seahorse
Extracellular Flux XFp Analyzer (Seahorse Bioscience,
Agilent Technologies). PC12-ND6 cells were seeded at a
density of 20,000 cells per well in triplicate on poly-Dlysine-coated plates and treated with PBS (control) or
NaBt (5 mM) for 24 h at 37 °C in 5% CO2 atmosphere.
Prior to the assay, the F12K medium was changed to
unbuffered Base Medium (Seahorse Bioscience) supplemented with 2 mM glutamine (Invitrogen), 2 mM pyruvate (Sigma), and 7.1 mM glucose (Sigma) adjusted to at
pH 7.4 with NaOH for 1 h at 37 °C. Using the XF Mito
Stress Test kit (Seahorse Bioscience), OCR and ECAR
were measured under basal conditions and after sequential injections of oligomycin (1 µM ﬁnal concentration),
FCCP (ﬂuoro 3-carbonyl cyanide-methoxyphenyl hydrazine; 1 and 2 µM ﬁnal concentrations) and a mix of
rotenone and antimycin A (1 µM ﬁnal concentration)
following the manufacturer’s recommendations. The data
were normalized to cell numbers and plotted as OCR
(oxygen consumption rate; pmol/min/cell) and ECAR
(extracellular acidiﬁcation rate; mpH/min/cell) as a
function of time.
Analysis of mitochondrial ultrastructure by transmission
electron microscopy

Control and NaBt-treated PC12-ND6 cells were ﬁxed in
2.5% glutaraldehyde (Electron Microscopy Sciences), 1%
paraformaldehyde in 0.12 M sodium cacodylate buffer
(Electron Microscopy Sciences) for 20 min at room temperature followed by 40 min on ice. Cells were then ﬁxed
for 1 h in 1% osmium tetroxide (Electron Microscopy
Sciences) followed by en-bloc staining overnight in 1%
aqueous uranyl acetate. The cells were then dehydrated
through a series of ethyl alcohol/deionized water solutions
and propylene oxide before inﬁltration with Embed812
epoxy resin. Blocks were cured for 48 h at 60 °C. Polymerized blocks were trimmed and 70 nm ultrathin sections were cut with a diamond knife on a Leica Ultramicut
EM UC7 and transferred onto 200 mesh copper grids.
Sections were counterstained with 1% ethanolic uranyl
acetate for 10 min and lead citrate for 2 min. Samples
were imaged with a FEI Talos F200X-transmission electron microscope (FEI Company) operating at an accelerating voltage of 80 kV equipped with a Ceta™ 16M
camera. For each condition, 20 cells were analyzed and
mitochondrial lengths were measured using Image J
software.
Assessment of ROS levels

When indicated, PC12-ND6 cells were treated with
NaBt (5 mM) for 48 h before being labeled with 0.5 µg/ml
Hoechst 33342 (Invitrogen) and 2.5 µM MitoSOX Red
(Invitrogen), as described57.
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ChIP-seq assay and analysis of ChIP-seq data

The ChIP-seq assay was performed with two biological
replicates per condition. Untreated and NaBt-treated
PC12-ND6 cells (6 × 106 per condition) were cross-linked
with 1% formaldehyde for 8 min. The recation was stopped
glycine (125 mM) for 5 min. Chromatin immunoprecipitation against H3K27Ac was performed by Diagenode
ChIP-seq Service (Cat# G02010000), as were subsequent
analyses. Brieﬂy, nuclei were extracted using Diagenode
iDeal ChIP-seq kit for histone and chromatin was sheared
with the Bioruptor® Pico (Diagenode). ChIP assay was
performed using 1 µg of anti-H3K27Ac Premium antibody
(Diagenode C15410196, lot A1723-0041D), rabbit IgG
(C15410206) as a negative control, or H3K4me3
(C154100003, lot 5051-001P) as a positive control. DNA
recovered from chromatin that was not immunoprecipated
was used as input. To quantify the ChIP-enriched and
input DNA, we used primers for TSH2B as a negative locus
(Diagenode, Cat# C17031043-50) and for GAPDH as a
positive locus (Diagenode, Cat# C17031046-50).
The input and ChIP samples were sequenced by Illumina HiSeq 2500. Quality control of sequencing reads was
performed using FAstQC. The 50-nt sequence reads were
aligned to the UCSC rat genome rn5 using the GreyListChIP Bioconductor package to identify regions
showing anomalously high signals and to ﬁlter the rat
samples accordingly. The samples were deduplicated
using the SAMtools version 1.3.1. Alignment coordinates
were converted to BED format using BEDTools v.2.17 and
H3K27ac peak calling was performed using SICER v1.160.
Differential H3K27ac binding was analyzed using the
DiffBind R/Bioconductor package61. The GO term
enrichment analysis was carried out on differentially
bound (DB) sites mapping in the TSS regions with at least
a two-fold change and FDR < 0.05 using the topGO R/
Bioconductor package and data from the org.Rn.eg.db
package62,63. Biological pathways of DB sites H3K27ac
were analyzed using ReactomePA and the Reactome
Pathway Knowledgebase64,65. The degree of connectivity
among the neuronal and MRPs proteins was analyzed
using STRING version 10.0 with the following parameters: textmining, experiments, databases, co-expression
and co-occurrence. The MRPs network was built using an
edge conﬁdence between 0.4 and 0.9. The neuronal network with no more than ten interactors for ﬁrst shell and
ﬁve interactors for second shell. The candidates neuronal
genes belong to axon guidance (FDR = 1.8 × 10−8), signal
transduction (FDR = 2.38 × 10−5), and cellular differentiation (FDR = 1.78 × 10−3).
ChIP-qPCR

ChIP was performed as described above. qPCR primer
sequences are listed in Table S4. A standard curve of input
DNA was run for each primer set, and the ampliﬁcation
Ofﬁcial journal of the Cell Death Differentiation Association
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efﬁciency, the melting proﬁle and the dimerization of the
primers (ampliﬁcation in non-template control) were calculated. qPCR was performed in duplicate using Realtime
qPCR (Sybr green) on ChIP DNA with LC96 (Roche). Data
are represented as % input ± SEM.
Statistical analysis

Statistical analyses were performed using the unpaired
Student's t-test, with p-value of less than 0.05 considered
statistically signiﬁcant. Data are expressed as mean ± S.D.
unless indicated otherwise.
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